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INTRODUCTION 
Analytical chemistry is often described as the area of chemistry responsible for 
characterizing the composition of matter, both qualitatively (what is present) and 
quantitatively (how much is present). Analytical chemistry is not a separate branch of 
chemistry, but simply the application of chemical knowledge. (David Harvey 1997) 
Pharmaceutical Analysis is the branch of chemistry involved in separating, identifying 
and determining the relative amounts of the components making up a sample of matter. It 
is mainly involved in the qualitative identification or detection of compounds and 
quantitative measurements of the substances present in bulk and pharmaceutical 
preparation. (Sharma BK 2000) 
Quantitative analysis constitutes the largest part of analytical chemistry and is related to 
the various methods and instrumentation employed in determining the amounts or 
concentration of constituents in samples. It is also one of the basic criteria in the field of 
pharmacy where quality is to be critically maintained. Analytical chemistry may be 
defined as the “Science and art of determining the composition of materials in terms of 
the elements or compounds contained”. Analytical method is a specific application of a 
technique to solve an analytical problem. (Michael E et al.,) 
1. DEGRADATION STUDIES  
A degradation product is defined as a chemical change in the drug molecule brought 
about over time and/or by action of, e.g., light, temperature, pH, or water or by reaction 
with an excipient and/or the immediate container/closure system (also called 
decomposition product). As per ICH guideline Stress testing helps determine the intrinsic 
stability of the molecule by establishing degradation pathways in order to identify the 
likely degradation products and to validate the stability indicating power of the analytical 
procedures used. Stress testing is conducted to provide data on forced decomposition 
products and decomposition mechanisms. The severe conditions that may be encountered 
during distribution can be covered by stress testing. These studies should stabilize the 
inherent stability characteristics of the molecule, such as the degradation pathways, and 
lead to identification of the degradation products and hence support the suitability of the 
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proposed analytical procedures. The detailed nature of the studies will depend on the 
individual drug substance and type of drug product. (Monika Bakshi et al.,(2002) 
 
The studies include the following 
• Development and validation of stability indicating method. 
• Determination of degradation pathways of drug substance and drug product. 
• Identification of degraded products in formulation that are related to drug substance 
versus those that are related to non-drug substance (Additives, Excipients) 
• Structural elucidation of degraded fragment. 
• Determination of intrinsic stability of drug substances. 
 
2.   IMPURITY STUDIES  
Impurities in a drug substance (a new chemical entity of therapeutic interest) or drug 
product (a drug substance formulated into a suitable product for administration to patient) 
may cause serious side effects and hence we need to isolate and characterize impurities. 
(FDA Guidance for Industry 2000) 
The following definition of impurity is currently under consideration by the regulatory 
bodies, which is likely to be included in the future guidance: 
Impurity: any entity of the drug substance (bulk material) or drug product (final 
container product) that is not the chemical entity defined as the drug substance, an 
excipient, or other additives to the drug product. 
Related substances: These substances are structurally related to the drug substance and 
may be identified or unidentified degradation products or impurities arising from a 
manufacturing process or during storage of a material.  
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As per ICH guidelines Impurities are listed alphabetically as given below. 
• By-product  
• Degradation product 
• Interaction product 
• Intermediate  
• Penultimate intermediate 
• Related product 
• Transformation product 
By-products: The unplanned compounds generated in the reaction to produce API are 
generally called by-products. For example during the synthesis of paracetamol we get 
diacetylated paracetamol which is the unexpected product called by-product. 
Degradation products: The compounds produced as a result of decomposition of the 
material of interest or API is often called degradation products. Due to degradation, 
impurities may also be formed. Degradation of beta lactum ring in penicillin and 
cephalosporin are the examples of degradation products.  
 
Related products: As suggested previously, the term “related products” tends to imply 
that the impurity is similar to the drug substance, and it thus tends to downplay the 
negativity frequently attached to the term “Impurity”. Transformation products: This is 
relatively a term that relates to theorized and non-theorized products that may be 
produced in the reaction. 
1.1.Classification of impurities 
According to ICH guidelines, impurities can be broadly classified in to three categories 
for the drug substance produced by chemical synthesis: 
• Organic impurities (starting materials, process-related products, inter- mediators, and 
degradation products). 
• Inorganic impurities (salts, catalysts, ligands, and heavy metals or other residual metals). 
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• Residual solvents (organic and inorganic liquids used during production and/or 
recrystallization). 
1.2. Need to Isolate and Characterize Impurities 
Impurities are generally assumed to be inferior to API because they might not have the 
same level of pharmacologic activity. However, they are not necessarily always inferior. 
From the standpoint of its usage, the drug substance is compromised in terms of purity 
even if it contains another material with superior pharmacological or toxicological 
properties. At first pass this may not be readily apparent; however, on further thought it 
will become clear that if we are to ensure that the accurate amount of the drug substance 
is being administered to the patient, we must assess its purity independent of the 
extraneous materials. Therefore, any extraneous material present in the drug substance or 
active ingredient must be considered an impurity even if it is totally inert or has superior 
pharmacologic properties, so that an appropriate evaluation of its content in the drug 
product can be made. The control of low-level impurities is of great importance when a 
drug is taken in large quantities. Impurities can also affect the purity of API or can be 
harmful to patients. 
 
CHARACTERIZATION OF IMPURITIES 
The degradation samples were characterized by following methods  
 UV spectroscopy 
 INFRARED spectroscopy 
 TLC 
 HPLC 
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DRUG PROFILE 
 
Alverine citrate is an anti cholinergic drug. Chemically it is an N-ethyl -3- phenyl-N-(3-
phenyl propyl )-1-propanamine. It is an official drug of B.P(B.P. 2009)  
EMPERICAL FORMULA: C2OH27N 
MOLECULAR WEIGHT   : 497.31   
STRUCTURE  
 
CATEGORY                       : Anti spasmodic 
 CAS number                       : 150-59-4 
 IUPAC NAME                   : Ethyl bis(3-phenyl propyl)amine  
DESCRIPTION: White to pale yellow fine powder 
SOLUBILITY:   Slightly soluble in water and in methylene chloride, sparingly soluble 
in ethanol. 
MELTING POINT: 104° C 
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 PHARMACODYNAMICS  
Alverine is a smooth muscle relaxant. Smooth muscle is a type of muscle that is not 
under voluntary control; it is the muscles present in places such as the gut and uterus. 
Alverine act directly through on the muscle in the gut, causing it to relax. This prevents 
the muscle spasms which occur in the gut in conditions such as irritable bowel syndrome 
and diverticular disease. Diverticular disease is a condition in which small pouches form 
in the gut lining. These pouches can trap particles of food and become inflamed and 
painful. It is also used to treat painful menstruation, which is caused by muscle spasm in 
the uterus. (Dysmenorrheal agent) 
 INDICATIONS  
Alverine citrate is used to relieve cramps or spasms of the stomach and intestines. It is 
also useful in treating irritable bowel syndrome (IBS) and similar conditions. It can also 
be used to relieve period of pain. ALC is also under investigation to increase the 
cytotoxic effects of the proteasome inhibitor MG132on breast cancer cells. 
 METABOLISM  
Rapidly converted to its primary metabolite, which is then further converted to two 
secondary metabolite  
HALF LIFE  
The plasma half -life averages 0.8 hours for Alverine and 5.7 hours for the active primary 
metabolite.  
 
SIDE EFFECTS  
Headache, Dizziness, itching, rash, jaundice. 
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TOXICITY:  
Can produce hypotension and atropine –like toxic effects 
 DOSAGE:  
60mg and 120mg of capsule  
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REVIEW OF LITERATURE 
 
Alverine citrate is an official drug in British Pharmacopeia. Review of literature indicate 
that sophisticated analytical method like H & mass for estimating Alverine in biological 
fluids, and simple Spectrophotometric methods have been reported.  
 
 Niraimathi.V et al., (2013) Validated method development for the quantification of 
Alverine citrate by spectrophotometry, IR Spectrophotometry RP-HPLC in 
pharmaceutical dosage Form. 
 
 JU,Wwang et al .,(2012)demonstrated the Dyclonine and ALC enhance cytotoxic effects 
of Proteasoma inhibitorMG132 on breast cancer cells  
 
 Rahul.C,et al.,(2011) to developed liquid chromatography/tandem mass spectrometry for 
the simultaneous determination of Alverine and its metabolite, mono hydroxyl Alverine 
in human plasma.  
 
 T.Wittman, et al.,(2010) had analyzed the efficacy of the ALC/simethicone combination 
on abdominal pain/discomfort in irritable bowel syndrome-a randomized, double-blind, 
placebo-controlled study  
 
 Chinmoy Ghosh, et al., (2010)had developed a rapid and most sensitive liquid 
chromatography/tandem mass spectrometry method for simultaneous determination of 
Alverine and its major metabolite, para hydroxyl Alverine in human plasma.  
 
 Wittmann et al., ., (2009) has reported that ALC/simethicone combination was 
significantly more effective than placebo in relieving abdominal/pain. 
 
 Noel.A.Gomes, Ardhoot laud, et al.,(2009) had developed validated LC-MS/MS 
method for determination of Alverine and one of its hydroxyl metabolites in human 
plasma along with its application to a bio equivalence study.  
 
 M.Hayase, et al.,(2007) studied evolving mechanisms of ALC on phasic smooth muscle.  
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 John W.  Dolan (2002) reported a stability indicating assays. 
 
 Monika Bakshi et al., (2002) developed a stability indicating assay methods. 
 
 Coelho AM, et al .,(2001)had studied the rectal antinociceptive properties of ALC are 
linked to antagonism at the 5-HTA,receptorsub type  
 
 FDA Guidance for Industry (2000) gave the information on Analytical procedures and 
method validation. 
 
 Abysique A et al.,(1999)studied the effects of ALC on cat intestinal mechanoreceptor 
response to chemical and mechanical stimuli. 
 
 G.J.Tudor, et al .,(1999)diagnosed a general practice study to compare ALC with 
mebeverine hydrochloride in the treatment of irritable bowel syndrome  
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AIM AND OBJECTIVE 
 
A degradation product is defined as a chemical change in the drug molecule brought 
about over time and/or by action of, e.g., light, temperature, pH, or water or by reaction 
with an excipient and/or the immediate container/closure system. 
 
Stress testing is conducted to provide data on forced decomposition products and 
decomposition mechanisms. The severe conditions that may be encountered during 
distribution can be covered by stress testing. 
Aim of the study is to conduct “FORCED DEGRADATION STUDIES OF 
ALVERINE CITRATE IN BULK AND FORMULATION BY UV, IR 
SPECTROPHOTOMETRY, TLC, AND RP-HPLC METHOD”. 
 
The study comprises of the following 
 
 To perform the Alkali hydrolysis, Oxidative degradation, and Thermal and 
Photolytic degradation. 
 Quantification of degraded samples by UV and HPLC. 
 Comparing the results of bulk and sample with standard. 
 Identification of degraded samples by TLC. 
 Identification of changes in functional group present in the degraded samples by 
IR. 
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MATERIALS AND METHODS 
MATERIALS AND INSTRUMENTS USED 
            DRUG SAMPLE & STUDY PRODUCTS 
               Alverine citrate was obtained from Apex Laboratories Ltd, Chennai, India. 
            Test product:  
            Alverine citrate capsules were purchased from local market. 
 
            CHEMICALS AND SOLVENTS USED FOR DEGRADATION: 
 Hydrochloric Acid                  – Merck, AR grade, Mumbai, India. 
 Hydrogen Peroxide (30%W/V)   – Merck, AR grade, Mumbai, India. 
 Sodium Hydroxide                      – Merck, AR grade ,  Mumbai, India 
 Chloroform                                 – Merck, AR grade , Mumbai, India 
 Ethanol                                        – Merck, AR grade , Mumbai, India 
 Methanol                                     – Merck, HPLC grade, Mumbai, India 
 Acetonitrile                                – Merck, HPLC grade, Mumbai, India 
 Water                                          – Double Distilled 
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 INSTRUMENTS USED: 
 Shimadzu 1650 UV Spectrophotometer    –  Double beam , UV Probe2.31 
  ABB-IR   , KBr Press                               –  AB MB 3000 
  Agilent HPLC                                – VWD detector, Chemstation 
 Shimadzu electronic balance                     – AX 200  
FORCED DEGRADATION 
Forced degradation studies are used to identify reactions which may occur to degrade a 
processed product. Purposeful degradation studies of the drug substance include 
appropriate solution and solid-state stress conditions (e.g., acid/base hydrolysis, heat, 
humidity, oxidation, and light exposure, in accordance with ICH guidelines). Guidelines 
from the United States Pharmacopoeia (USP), ICH, and FDA provide a brief outline of 
drug substance conditions.  
ANALYTICAL PROCEDURES 
Degraded samples were analyzed using Spectrophotometric methods like UV, IR and 
chromatographic methods like TLC and HPLC. The assays of degraded samples were 
carried out by UV and HPLC and the changes in the functional group of drug were 
detected by IR spectroscopy. Degraded products were identified by TLC. 
HYDROLYTIC DEGRADTION  
Hydrolytic stress testing is performed to force the degradation of a drug substance to its 
primary degradation products by exposure to acidic and basic conditions over time. 
Functional groups likely to introduce acid/base hydrolysis are amides (lactams), esters 
(lactones), carbamates, imides, imines, alcohols (epimerization for chiral centres), and 
aryl amines. To initiate acid/base studies, a preliminary solubility screen of the drug 
substance is performed. Solubility of at least 1 mg/mL in 0.1N acidic and basic condition 
is recommended for the acid/base stress testing; however, concentrations less than 1 
mg/mL can be used if solubility is an issue. In some cases, a co-solvent may be necessary 
to achieve the target concentration.  
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OXIDATIVE DEGRADATION 
The increase in oxidation state of an atom through a chemical reaction is known as an 
oxidation. Oxidative studies are executed to force the degradation of drug substances to 
determine the primary oxidative degradation products. Oxidative degradation is a serious 
stability problem and can cause a major halt in pharmaceutical development. Stability 
Guidelines state that a high oxygen atmosphere should be evaluated in stability studies on 
solutions or suspensions of the bulk drug substance. Mostly Oxidative degradation is 
done by Hydrogen peroxide. The concentration of hydrogen peroxide varies from 1% to 
30%. 
 
PHOTOLYTIC DEGRADATION 
The goal of the photo stability studies is to force the degradation of drug substances via 
UV and fluorescent conditions over time to determine the primary degradation products. 
UV and visible light are the most energetic electromagnetic radiation sources to which 
pharmaceutical drug substances and drug products are typically exposed. A molecule 
absorbs light when an absorption band exists that overlaps to some extent with the 
incident light energy and a valence electron in the relevant chromophore is raised to an 
excited state. Light stress conditions can also induce photo oxidation by free radical 
mechanisms. The sample was placed in sun light to produce photolytic degradation. 
 
THERMAL DEGRADATION 
The goal of thermal and thermal studies is to force the degradation of drug substances 
over time to determine the primary thermal degradation products. Thermal degradation is 
used to detect the ability of samples withstand in different temperature. Thermal 
degradation was induced by placing the sample in hot oven. The temperature range for 
thermal degradation is from 40ºC to 100ºC. 
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1. UV SPECTROSCOPY 
Ultraviolet Spectroscopy is concerned with the study of absorption of UV radiation which 
ranges from 200 nm to 400 nm. Any molecule has ‘n’ or ‘pi’ or ‘σ’ or a combination of 
these electrons. These bonding (σ and pi) and nonbonding (n) electrons absorb the 
characteristic radiation and undergoes transition from ground state to excited state. By the 
characteristic absorption peaks, the natures of the electrons present and hence the 
molecule structure can be elucidated. UV spectroscopy works on Beer Lamberts law 
Principle. UV is mainly used in the determination of assay value of samples based on the 
absorption of samples. In degradation studies UV can show the variation in maximum 
wavelength of the degraded samples. Degraded cannot give the same maximum 
wavelength as standard. Comparing the standard spectrum with degraded sample 
spectrum can differentiate the degradation. 
 
 
Intraday scheme of UV study for Bulk& Formulation (Table: 1) 
 
                                                
 
 
 
DEGRADATION 
EXPERIMENTAL 
CONDITIONS 
STORAGE 
CONDITION 
SAMPLING TIME 
 
Control Sample 
(No acid or base) 
Room temperature 30,60,90mins 
Hydrolysis 
0.1N HCL Room temperature 30,60,90mins 
Acid Control (no API) Room temperature 30,60,90mins 
Oxidative 
30%H2O2 Room temperature 30,60,90mins 
30%H2O2(no API) Room temperature 30,60,90mins 
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Interday scheme of UV study for Bulk& Formulation (Table: 2) 
                                                      
 
 
 
 
 
 
 
 
 
 
 
 
 
Materials and Methods 
All absorption spectrums were measured by Shimadzu UV-1650PC spectrophotometer 
with a scanning speed of 200nm/min and a band width of 2.0nm equipped with 1cm 
matched quartz cells. 
Reagents used 
0.1N Hydrochloric acid 
30% Hydrogen peroxide 
Distilled water 
 
 
 
 
DEGRADATION 
EXPERIMENTAL 
CONDITIONS 
STORAGE 
CONDITION 
SAMPLING 
TIME 
 
Control Sample 
(No acid or base) 
Room temperature 1,3,5 days 
Hydrolysis 
0.1N HCL Room temperature 1,3,5 days 
Acid Control (no API) Room temperature 1,3,5 days 
Oxidative 
30%H2O2 Room temperature 1,3,5 days 
30%H2O2(no API) Room temperature 1,3,5 days 
Thermal Heating chamber 50ºC 1,3,5 days 
Photolysis Powder form Sun Light 1,3,5 days 
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 PREPARATION OF REAGENTS 
 Preparation of 0.1N Sodium Hydroxide: 
4gms of sodium hydroxide pellets were weighed and dissolved in small amount of 
distilled water then made up the volume to 1000mL. 
Preparation of 0.1N Hydrochloric acid 
8.33mL of concentrated Hydrochloric acid was measured and diluted with distilled water 
to 1000mL. 
Preparation of 30% Hydrogen peroxide 
300 mL of Hydrogen peroxide was diluted with distilled water and the volume made up 
to 1000mL. 
1.1. INTRADAY STUDY OF  HYDROLYTIC DEGRADATION USING 0.1N HCl 
 
Standard preparation 
Alverine citrate was transferred to volumetric flask and dissolved in distilled water to 
achieve a concentration of 1mg/mL. The solution was kept at room temperature. An 
aliquot solution was diluted with distilled water to get a final concentration of 100µg/mL. 
The solution was scanned in the UV region and the maximum absorbance was recorded 
at 258nm. 
Bulk preparation (stress) 
25mg of Alverine citrate was transferred to volumetric flask and dissolved in 0.1N 
Hydrochloric acid to achieve a concentration of 1mg/mL. The solution was kept at room 
temperature.  After 30mins, an aliquot solution was diluted with distilled water to get a 
final concentration of 100µg/mL. The solution was scanned in the UV region and the 
maximum absorbance was recorded at 258nm. The same procedure was repeated for 
60mins, and 90mins time interval. 
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Sample preparation (stress) 
25mg equivalent of Alverine citrate capsules were weighed and transferred to volumetric 
flask; dissolved in 0.1N Hydrochloric acid was added to achieve a concentration of 
1mg/mL. The solution was kept at room temperature.  After 30mins, an aliquot solution 
was diluted with distilled water to get a final concentration of 100µg/mL. The solution 
was scanned in the UV region and the maximum absorbance was recorded at 258nm. The 
same procedure was repeated for 60mins, and 90mins time interval. 
Blank preparation 
25mL of 0.1N HCl solution was taken in a 25mL volumetric flask. The solution was kept 
at room temperature. After 30mins, an aliquot solution was diluted with distilled water to 
get a final concentration. This is used as a blank. 
The procedure was repeated thrice. After the stipulated time, the absorption of the 
resulting solution showed maxima 258nm against reagent blank treated in the same way. 
Three such determinations were made and the assay value was estimated. The obtained 
values were tabulated. 
The percentage content of bulk was determined by following formula 
	
 =
	.× .	 × . 
 × 	
	.× 
. .× .	 × 
 
 
The amount of present was determined by following formula 

	 = 	
	.× .	 × . 
 × 	
	.		 × .	
	
. .× .	 × 
 
 
Percentage content of Alverine citrate was determined by following formula 
 
	
 =

	
	
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OXIDATIVE DEGRADATION USING 30% H2O2 
Bulk preparation (stress)  
25mg of Alverine citrate was transferred to volumetric flask and dissolved in 30% 
Hydrogen peroxide to achieve a concentration of 1mg/mL. The solution was kept at room 
temperature. After 30mins, an aliquot solution was diluted with distilled water to get a 
final concentration of 100µg/mL. The solution was scanned in the UV region and the 
maximum absorbance was recorded at 258nm. The same procedure was repeated for 
60mins, and 90mins time interval. 
Sample preparation (stress) 
25mg equivalent of Alverine citrate capsules were weighed and transferred to volumetric 
flask; dissolved in 30% Hydrogen peroxide to achieve a concentration of 1mg/mL. The 
solution was kept at room temperature. After 30mins, the solution was scanned in the UV 
region and the maximum absorbance was recorded at 258nm. The same procedure was 
repeated for 60mins, and 90mins time interval. 
Blank preparation 
50mL of 30% H2O2 solution was taken in a 25mL volumetric flask. The solution was kept 
at room temperature. After 30mins, an aliquot solution was diluted with distilled water to 
get a final concentration. This is used as a blank. 
The procedure was repeated thrice. After the stipulated time, the absorption of the 
resulting solution showed maxima 258nm against reagent blank treated in the same way. 
Three such determinations were made and the assay value was estimated. The obtained 
values were tabulated. 
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1.2. INTERDAY HYDROLYTIC FORCED DEGRADATION STUDY USING  
0.1N HCl 
Bulk preparation (stress) 
25mg of Alverine citrate was transferred to volumetric flask and 0.1N Hydrochloric acid 
to achieve a concentration of 1mg/mL. The solution was kept at room temperature. Then 
the next day, an aliquot solution was diluted with distilled water to get a final 
concentration of 100µg/mL. The solution was scanned in the UV region and the 
maximum absorbance was recorded at 258nm. The same procedure was repeated for 3rd 
and 5th day time interval. The obtained spectrum is compared with standard spectrum. 
Sample preparation (stress) 
25mg equivalent of Alverine citrate capsules were crushed weighed and transferred to 
volumetric flask dissolved0.1N Hydrochloric acid to achieve a concentration of 1mg/mL. 
The solution was kept at room temperature. The next day (1st day), an aliquot solution 
was diluted with distilled water to get a final concentration of 100µg/mL.. The solution 
was scanned in the UV region and the maximum absorbance was recorded at 258nm. The 
same procedure was repeated for 3rd and 5th day time interval. 
Blank preparation 
25mL of 0.1N HCl solution was taken in a 25mL volumetric flask. The solution was kept 
at room temperature. The next day, an aliquot solution was diluted with distilled water to 
get a final concentration. This procedure is repeated for 3rd and 5th day. 
The procedure was repeated thrice. After the stipulated time, the absorption of the 
resulting solution showed maxima 258nm against reagent blank treated in the same way. 
Three such determinations were made and the assay value was estimated. 
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OXIDATIVE DEGRADATION USING 30%H2O2 
Bulk preparation (stress) 
25mg of Alverine citrate was weighed and transferred to volumetric flask and dissolved 
in 30% Hydrogen peroxide to achieve a concentration of 1mg/mL. The solution was kept 
at room temperature. Then the next day, an aliquot solution was diluted with distilled 
water to get a final concentration of 100µg/mL. The solution was scanned in the UV 
region and the maximum absorbance was recorded at 258nm. The same procedure was 
repeated for 3rd and 5th day time interval. The obtained spectrum is compared with 
standard spectrum. 
Sample preparation (stress) 
25mg equivalent of Alverine citrate capsules were crushed weighed and transferred to 
volumetric flask dissolved in 30% Hydrogen peroxide to achieve a concentration of 
1mg/mL. The solution was kept at room temperature. The next day (1st day), an aliquot 
solution was diluted with distilled water to get a final concentration of 100µg/mL. The 
solution was scanned in the UV region and the maximum absorbance was recorded at 
258nm. The same procedure was repeated for 3rd and 5th day time interval. 
Blank preparation 
25mL of 30% Hydrogen peroxide solution was taken in a 25mL volumetric flask. The 
solution was kept at room temperature. The next day, an aliquot solution was diluted with 
distilled water to get a final concentration. This procedure is repeated for 3rd and 5th day. 
The procedure was repeated thrice. After the stipulated time, the absorption of the 
resulting solution showed maxima 258nm against reagent blank treated in the same way. 
Three such determinations were made and the assay value was estimated.  
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THERMAL DEGRADATION AT 50ºC 
Bulk preparation (stress) 
1g of Alverine citrate bulk was weighed and transferred to a petri dish. This petri dish 
was placed in a hot air over at the temperature of 50ºC. The next day 25mg Alverine 
citrate bulk was weighed from a petri dish and transferred to 25mL volumetric flask. It 
was dissolved in distilled water and the volume made up to25mL. An aliquot solution 
was diluted with distilled water to get a final concentration of 100µg/mL. The same 
procedure was repeated for 3rd and 5th day.  
Sample preparation (stress) 
1g of Alverine citrate capsules were weighed and transferred to a petri dish. This petri 
dish was placed in a hot air over at the temperature of 50ºC. The next day 25mg 
equivalent of Alverine citrate capsule was weighed from a petri dish and transferred to 
25mL volumetric flask. It was dissolved in distilled water and the volume made up to 
25mL. An aliquot solution was diluted with distilled water to get a final concentration of 
100µg/mL. the same procedure was repeated for 3rd and 5th day.  
Blank preparation 
Distilled water was used as blank 
PHOTOLYTIC DEGRADATION USING SUN LIGHT 
Bulk preparation (stress) 
1g of Alverine citrate bulk was weighed and transferred to a petri dish. This petri dish 
was placed in a sun light. The next day 25mg Alverine citrate bulk was weighed from a 
petri dish and transferred to 25mL volumetric flask. It was dissolved in distilled water 
and the volume made up to 25mL. An aliquot solution was diluted with distilled water to 
get a final concentration of 100µg/mL. The same procedure was repeated for 3rd and 5th 
day.  
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Sample preparation (stress) 
1g of Alverine citrate capsules were weighed and transferred to a petri dish. This petri 
dish was placed in a sun light. The next day 25mg equivalent of Alverine citrate was 
taken from the petri dish and transferred to 25mL volumetric flask. It was dissolved in 
distilled water and the volume made up to 25mL. An aliquot solution was diluted with 
distilled water to get a final concentration of 100µg/mL. The same procedure was 
repeated for 3rd and 5th day.  
Blank preparation 
Distilled water was used as a blank. 
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2. INFRARED SPECTROCOPY 
An invaluable tool in organic structure determination and verification involves the class 
of electromagnetic (EM) radiation with frequencies between 4000 and 400cm-1  
 (Wavenumbers). The category of EM radiation is termed infrared (IR) radiation, and its 
application to organic chemistry known as IR spectroscopy. Radiation in this region can 
be utilized in organic structure determination by making use of the fact that it is absorbed 
by interatomic bonds in organic compounds. Chemical bonds in different environments 
will absorb varying intensities and at varying frequencies. Stretching absorptions usually 
produce stronger peaks than bending, however the weaker bending absorptions can be 
useful in differentiating similar types of bonds (e.g. aromatic substitution). It is also 
important to note that symmetrical vibrations do not cause absorption of IR radiation. IR 
is mainly used in the detection of functional groups present in the compounds. 
Comparing the standard spectrum with sample we can identify the changes of functional 
groups in the degraded sample. It is only applicable for solid samples undergoing 
degradation. 
 
 Interday scheme of IR study for Bulk& Formulation (Table: 3) 
 
 
 
 
 
 
 
 
 
Degradation Type Material(solid) Storage 
condition 
Sampling Time 
Normal 
Bulk Room temperature 1,3,5days 
Sample Room temperature 1,3,5days 
Photolysis 
Bulk Sunlight 1,3,5days 
Sample Sunlight 1,3,5days 
Thermal(Heating 
Chamber) 
Bulk 50ºC 1,3,5days 
Sample 50ºC 1,3,5days 
                                                                                                                                          MATERIALS AND METHODS 
 
DEPARTMENT OF PHARMACEUTICAL CHEMISTRY Page 24 
Apparatus  
 All spectral measurements were made on ABB-IR (model no.MB3000) with KBr press 
(model no. M15). 
General Procedure 
Alverine citrate capsules were weighed and transferred into a petri dish. The first one was 
kept at room temperature, the second done was kept at chamber at 50ºC, and the third one 
was kept at sunlight. This was referred as 0 day. The bulk drug was weighed and 
transferred into 3 different petri dishes. The same procedure was repeated for bulk drug. 
Standard preparation: 
The first day standard of the Alverine citrate was weighed and reground with dry KBr 
using agate mortar and pestle. The KBr discs were prepared by using KBr pellet press 
instrument. Then the % transmittance of the standard was measured. The same procedure 
was repeated for 3rdand 5rdday. The % transmittance was recorded in similar way. 
Bulk preparation (stress) 
The next day, required bulk drug has been taken from petri dish. The required amount of 
bulk drug was reground with dry KBr using agate mortar and pestle. The discs were 
prepared by using KBr press instrument. Then the percentage transmittance of the bulk 
drug was measured. The spectrum obtained from the degraded sample was compared 
with standard spectrum. The same procedure was repeated for 3rd and 5th day. The 
percentage transmittance was recorded in similar way. 
Sample preparation (stress) 
The next day (1st) day, required sample has been taken from petri dish. The required 
amount of sample was reground with dry KBr using agate mortar and pestle. The discs 
were prepared by using KBr press instrument. Then the percentage transmittance of the 
sample was measured. The same procedure was repeated for 3rd and 5th day. The 
percentage transmittance was recorded in similar way. 
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THERMAL-50ºC: 
Bulk preparation (stress) 
The next day, the bulk from chamber was removed and the required quantity has been 
taken from the petri dish. It was kept in the same place. The required amount bulk drug 
was reground with dry KBr agate mortar and pestle .The discs were prepared by using 
KBr press instrument. Then the percentage transmittance of the bulk drug was measured. 
The same procedure was repeated for 3rd and 5th day. The percentage transmittance was 
recorded in similar way. 
Sample preparation (stress) 
Similar bulk procedure was followed. 
SUNLIGHT: 
Bulk preparation (stress) 
The next day (1st) day, the required quantity has been taken from the petri dish. It was 
kept in the same place .The required amount of bulk was reground with dry KBr to using 
agate mortar and pestle. The discs were prepared by using KBr press instrument. Then 
the percentage transmittance of the bulk was measured .Compared the spectrum with 
standard spectrum. The same procedure was repeated foe 3rd and 5th day. The % 
transmittance was recorded in similar way. 
Sample preparation (stress) 
Similar bulk procedure was followed. 
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3. RP-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY: 
High Performance Liquid Chromatography: 
High performance Liquid Chromatography (HPLC) is a form of liquid chromatography 
to separate compounds that are dissolved in solution. This technique is based on the 
modes of separation like adsorption, partition, including reverse phase partition, ion–
exchange and gel permeation. HPLC instrument consists of a reservoir of mobile phase, a 
pump, an injector, a separation column, and a detector; Compounds are separated by 
injecting a plug of the sample mixture onto the column. The different compounds in the 
mixture pass through the column at different rates due to differences in their partitioning 
behaviour between the mobile liquid phase and the stationary phase. 
                                                      
 
Intraday scheme of HPLC study for Bulk& Formulation (Table no: 4) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DEGRADATION 
EXPERIMENTAL 
CONDITIONS 
STORAGE 
CONDITION 
SAMPLING 
TIME 
 
Control Sample 
(No acid or base) 
Room temperature 30,60,90mins 
Hydrolysis 
0.1N HCL Room temperature 30,60,90mins 
Acid Control (no API) Room temperature 30,60,90mins 
Oxidative 
30%H2O2 Room temperature 30,60,90mins 
30%H2O2(no API) Room temperature 30,60,90mins 
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Interday scheme of HPLC study for Bulk& Formulation (Table: 5) 
 
 
R
e 
 
 
 
 
 
 
Reagents and Chemicals Used For HPLC 
 Acetonitrile HPLC Grade. 
 Methanol  
 Distilled water 
 
Preparation of mobile phase: 
Mobile phase was prepared with 50 % of Acetonitrile and 50% of Sodium Lauryl 
Sulphate (1:1) respectively. The mobile phase was prepared freshly, filtered through a 
0.45µgm membrane filter and sonicated before use. 
Standard preparation: 
Alverine was transferred to volumetric flask and dissolved in methanol to achieve a 
concentration of 1mgmL-1 .An aliquot solution was diluted with distilled water to get a 
final concentration of 100µg/mL. 
 
 
DEGRADATION 
EXPERIMENTAL 
CONDITIONS 
STORAGE 
CONDITION 
SAMPLING 
TIME 
 
Control Sample 
(No acid or base) 
Room temperature 1,3,5 days 
Hydrolysis 
0.1N HCL Room temperature 1,3,5 days 
Acid Control (no API) Room temperature 1,3,5 days 
Oxidative 
30%H2O2 Room temperature 1,3,5 days 
30%H2O2(no API) Room temperature 1,3,5 days 
Thermal Heating chamber 50ºC 1,3,5 days 
Photolysis Powder form Sun Light 1,3,5 days 
                                                                                                                                          MATERIALS AND METHODS 
 
DEPARTMENT OF PHARMACEUTICAL CHEMISTRY Page 28 
 
Bulk preparation: 
25mg of Alverine bulk was weighed, transferred to volumetric flask and dissolved in 
distilled water to achieve a concentration of 1mg/mL. An aliquot solution was diluted 
with water to get a final concentration of 100µg/mL. 
Sample preparation:  
25mg equivalent of Alverine capsules were weighed transferred to volumetric flask and 
dissolved in distilled water to achieve a concentration of 1mg/mL. An aliquot solution 
was diluted with water to get a final concentration of 100µg/mL. 
Before the sample, bulk and standard solutions were filtered through a 0.45µgm 
membrane filter. 
Chromatographic conditions: 
Column              : C 18 (Reversed Phase) 
Stationary Phase:  Silica 
Elution type       :  Isocratic 
Mobile phase     : Acetonitrile: Sodium Lauryl Sulphate (1:1)     
Detector             : PDA detector 
Flow rate          : 1 mL/min. 
 
Determination of Retention Time: 
The mobile phase was injected first to determine the absence of any interference with the 
base line. The retention time was then determined by injecting 20 µL of the standard in 
the column and the retention time was determined using 220 nm as the detection 
wavelength. The retention time was 6.8mins for Alverine citrate. 
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Analysis of sample solution: 
The sample solution was diluted to get the required concentration and used for the 
estimation of Alverine citrate. 20 µg/mL of the solution was injected into the column, 
retention time and peak area was determined. 
Assay: 
20 µg/mL of standard and sample solution were injected separately with the flow rate of 
1mL/minute of the mobile phase containing Acetonitrile: Sodium Lauryl Sulphate (1:1)    
proportion. The amount of Alverine citrate was calculated from the obtained 
chromatogram. 
 

 =
. × . × . 
 × . × 

.  × . × 
 
 
Percentage content of Alverine citrate 
	
 =

	
	
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3.1 INTRADAY STUDY BY RP-HPLC OF BULK AND FORMULATION 
Hydrolytic degradation using 0.1N HCl 
Bulk preparation (stress) 
25mg of Alverine citrate was weighed and transferred to a 25mL volumetric flask. It was 
dissolved in methanol and the volume made up to 25mL using 0.1N HCl to achieve a 
concentration of 1mg/mL. After 90mins, an aliquot solution was diluted with mobile 
phase to get a concentration of 100µg/mL. The retention time and peak area were 
determined by recording the chromatograms. 
Sample preparation (stress) 
25mgequivalent of Alverine citrate capsules were weighed and transferred to a 25mL 
volumetric flask. It was dissolved in methanol and the volume made up to 25mL 
using0.1N HCl to achieve a concentration of 1mg/mL. After 90mins, an aliquot solution 
was diluted with mobile phase to get a concentration of 100µg/mL. The retention time 
and peak area were determined by recording the chromatograms. 
Blank preparation 
25mL of 0.1N HCl was taken in a 25mL volumetric flask. After 90mins, an aliquot 
solution was diluted with distilled water to get a final concentration. The blank solution 
was injected in to the column. 
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OXIDATIVE DEGRADATION USING 30% H2O2 
Bulk preparation (stress) 
25mg of Alverine citrate was weighed and transferred to a 25mL volumetric flask. It was 
dissolved in methanol and the volume made up to 25mL using 30% H2O2 to achieve a 
concentration of 1mg/mL. After 90mins, an aliquot solution was diluted with mobile 
phase to get a concentration of 100µg/mL. The retention time and peak area were 
determined by recording the chromatograms. 
Sample preparation (stress) 
25mg equivalent of Alverine citrate capsules were weighed and transferred to a 25mL 
volumetric flask. It was dissolved in methanol and the volume made up to 25mL using 
30% H2O2 to achieve a concentration of 1mg/mL. After 90mins, an aliquot solution was 
diluted with mobile phase to get a concentration of 100µg/mL. The retention time and 
peak area were determined by recording the chromatograms. 
Blank preparation 
25mL of 30% H2O2 was taken in a 25mL volumetric flask. After 90mins, an aliquot 
amount of solution was used to get a final concentration. The blank solution was injected 
in to the column. 
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3.1 INTERDAY STUDY BY RP-HPLC OF BULK AND FORMULATION 
Hydrolytic degradation using 0.1N HCl 
Bulk preparation (stress) 
25mg of Alverine citrate was weighed and transferred to a 25mL volumetric flask. It was 
dissolved in methanol and the volume made up to 25mL using 0.1N HCl to achieve a 
concentration of 1mg/mL. The third day, an aliquot solution was diluted with mobile 
phase to get a concentration of 100µg/mL. The retention time and peak area were 
determined by recording the chromatograms. 
Sample preparation (stress) 
25mg equivalent of Alverine citrate capsules were weighed and transferred to a 25mL 
volumetric flask. It was dissolved in methanol and the volume made up to 25mL 
using0.1N HCl to achieve a concentration of 1mg/mL. The third day, an aliquot solution 
was diluted with mobile phase to get a concentration of 100µg/mL. The retention time 
and peak area were determined by recording the chromatograms. 
Blank preparation 
25mL of 0.1N HCl was taken in a 25mL volumetric flask. The third day, an aliquot 
solution was diluted with distilled water to get a final concentration. The blank solution 
was injected in to the column. 
OXIDATIVE DEGRADATION USING 30% H2O2 
Bulk preparation (stress) 
25mg of Alverine citrate was weighed and transferred to a 25mL volumetric flask. It was 
dissolved in methanol and the volume made up to 25mL using 30% H2O2 to achieve a 
concentration of 1mg/mL. The third day, an aliquot solution was diluted with mobile 
phase to get a concentration of 100µg/mL. The retention time and peak area were 
determined by recording the chromatograms. 
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Sample preparation (stress) 
25mg equivalent of Alverine citrate capsules were weighed and transferred to a 25mL 
volumetric flask. It was dissolved in methanol and the volume made up to 25mL using 
30% H2O2 to achieve a concentration of 1mg/mL. The third day, an aliquot solution was 
diluted with mobile phase to get a concentration of 100µg/mL. The retention time and 
peak area were determined by recording the chromatograms. 
Blank preparation 
25mL of 30% H2O2 was taken in a 25mL volumetric flask. The third day, an aliquot 
solution was diluted with distilled water to get a final concentration. The blank solution 
was injected in to the column. 
THERMAL DEGRADATION AT 50ºC 
Bulk preparation (stress) 
1g of Alverine citrate bulk was weighed and transferred to a Petri dish. This Petri dish 
was placed in a hot air over at the temperature of 50ºC. The third day, 25mg Alverine 
citrate bulk was weighed from a Petri dish and transferred to 25mL volumetric flask. It 
was dissolved in mobile phase and the volume made up to 25mL. An aliquot solution was 
diluted with mobile phase to get a final concentration of 100µg/mL. 
Sample preparation (stress) 
1g of Alverine citrate capsules were weighed and transferred to a Petri dish. This Petri 
dish was placed in a hot air over at the temperature of 50ºC. The third day, 25mg 
equivalent of Alverine citrate tablet was weighed from a Petri dish and transferred to 
25mL volumetric flask. It was dissolved in ethanol and the volume made up to 25mL. An 
aliquot solution was diluted with mobile phase to get a final concentration of 100µg/mL. 
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PHOTOLYTIC DEGRADATION USING SUN LIGHT 
Bulk preparation (stress) 
1g of Alverine citrate bulk was weighed and transferred to a petri dish. This petri dish 
was placed in a sun light. The 3rd day 25mg Alverine citrate bulk was weighed from a 
petri dish and transferred to 25mL volumetric flask. It was dissolved in ethanol and the 
volume made up to 25mL. An aliquot solution was diluted with mobile phase to get a 
final concentration of 100µg/mL.  
Sample preparation (stress) 
1g of Alverine citrate capsules were weighed and transferred to a petri dish. This petri 
dish was placed in a sun light. The 3rd day 25mg equivalent of Alverine citrate was taken 
from the petri dish and transferred to 25mL volumetric flask. It was dissolved in ethanol 
and the volume made up to 25mL. An aliquot solution was diluted with mobile phase to 
get a final concentration of 100µg/mL. 
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4. THIN LAYER CHROMATOGRAPHY 
Thin Layer Chromatography (TLC) is a chromatography technique used to separate non-
volatile mixtures. TLC is performed on a sheet of glass, plastic, or aluminium foil, which 
is coated with a thin layer of adsorbent material, usually silica gel, aluminium oxide, 
or cellulose. This layer of adsorbent is known as the stationary phase. After the sample 
has been applied on the plate, a solvent or solvent mixture (known as the mobile phase) is 
drawn up the plate via capillary action. Because different analytes ascend the TLC plate 
at different rates, separation is achieved. Thin layer chromatography can be used to 
monitor the progress of a reaction, identify the compounds present in a given mixture, 
and determine the purity of a substance. In degradation studies it is used to  
• To identify the degradation(whether the degradation occurred or not)  
• To detect impurities (like no. of impurities formed) 
 
Presences of impurities were detected by number of spots and intensity of spots after the 
detection. Various mobile phases are given below tried for Alverine citrate.  
 
 Hexane: Ethyl acetate (6:4) 
 Chloroform: Toluene: Methanol (6:2:2) 
 Chloroform: Methanol: Water (6:2:2) 
 Chloroform: Methanol (5:5) 
 Chloroform: Ethanol (9:1) 
 
Mobile phase containing Chloroform and Methanol (9:1) were chosen for the study as it 
gave better resolution. Detection was carried out at by using iodine chamber. 
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 Rf values were calculated by following formula 
 
 ! =
"#$%&'()	%*&+),,)-	./	$0,1%)
"#$%&'()	%*&+),,)-	./	$0,+)'%
 
 
Mobile phase preparation 
Mobile phase was prepared by using chloroform and methanol in the ration of 9:1. Then 
the mobile phase was allowed for saturation. Mobile phase should be prepared freshly. 
 
Interday scheme of study of Bulk & Formulation (Table: 6) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DEGRADATION 
EXPERIMENTAL 
CONDITIONS 
STORAGE 
CONDITION 
SAMPLING 
TIME 
 
Control Sample 
(No acid or base) 
Room temperature 90mins 
Hydrolysis 
0.1N HCl Room temperature 90mins 
Acid Control (no API) Room temperature 90mins 
Oxidative 
30%H2O2 Room temperature 90mins 
30%H2O2(no API) Room temperature 90mins 
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Interday scheme of study of Bulk & Formulation (Table: 7) 
 
 
 
 
 
 
 
 
 
 
 
 
DEGRADATION 
EXPERIMENTAL 
CONDITIONS 
STORAGE 
CONDITION 
SAMPLING 
TIME 
 
Control Sample 
(No acid or base) 
Room temperature 3rd day 
Hydrolysis 
0.1N HCl Room temperature 3rd day 
Acid Control (no API) Room temperature 3rd day 
Oxidative 
30%H2O2 Room temperature 3rd day 
30%H2O2(no API) Room temperature 3rd day 
 
Thermal 
 
Heating chamber 
 
50ºC 
 
3rd day 
 
Photolysis 
 
Powder form 
 
Sunlight 
 
3rd day 
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4.1. INTRADAY HYDROLYTIC DEGRADATION USING 0.1N HCl 
 
Preparation of standard  
Small amount of Alverine citrate was dissolved in methanol and used as a standard. 
Standard should be prepared freshly.  
 
Detecting agent: Iodine chamber 
 
Bulk preparation (stress) 
25mg of Alverine citrate was transferred to volumetric flask and dissolved in 0.1N 
Hydrochloric acid to achieve a concentration of 1mg/mL. The solution was kept at room 
temperature.  After 90mins, the sample was spotted on the TLC plate using micropipette. 
This was marked as P. Then standard was spotted and denoted as D. Then the TLC was 
placed in the mobile phase containing TLC chamber for elution. After sufficient elution 
TLC plate was removed from the TLC chamber and placed in an iodine chamber for 
detection. Rf value was calculated. 
Sample preparation (stress) 
25mg equivalent of Alverine citrate capsules were weighed and transferred to volumetric 
flask; dissolved in 0.1N Hydrochloric acid was added to achieve a concentration of 
1mg/mL. The solution was kept at room temperature. After 90mins, the sample was 
spotted on the TLC plate using micropipette. This was marked as P. Then standard was 
spotted and denoted as D. Then the TLC was placed in the TLC chamber containing 
mobile phase for elution. After sufficient elution TLC plate was removed from the TLC 
chamber and placed in an iodine chamber for detection. 
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OXIDATIVE DEGRADATION USING 30%H2O2 
Bulk preparation (stress) 
25mg of Alverine citrate was weighed and transferred to volumetric flask and dissolved 
in 30% Hydrogen peroxide to achieve a concentration of 1mg/mL. The solution was kept 
at room temperature. After 90mins, the sample was spotted on the TLC plate using 
micropipette. This was marked as P. Then standard was spotted and denoted as D.  Then 
the TLC was placed in the TLC chamber containing mobile phase for elution. After 
sufficient elution TLC plate was removed from the TLC chamber and placed in an iodine 
chamber for detection. 
 
Sample preparation (stress) 
25mg equivalent of Alverine citrate capsules were weighed and transferred to volumetric 
flask dissolved in 30%Hydrogen peroxide to achieve a concentration of 1mg/mL. The 
solution was kept at room temperature. After 90mins, the sample was spotted on the TLC 
plate using micropipette. This was marked as P. Then standard was spotted and denoted 
as D. Then the TLC was placed in the TLC chamber containing mobile phase for elution. 
After sufficient elution TLC plate was removed from the TLC chamber and placed in an 
iodine chamber for detection. 
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4.2. INTERDAY FORCED DEGRADATION STUDY USING 0.1N HCl and 30% 
H2O2 
Same as the intraday procedure was adopted for the interday degradation. After three 
days the bulk and sample were collected.  
THERMAL DEGRADATION AT 50ºC 
Bulk preparation (stress) 
1g of Alverine citrate bulk was weighed and transferred to a petri dish. This petri dish 
was placed in a hot air over at the temperature of 50ºC. The third day, the sample was 
spotted on the TLC plate using micropipette. This was marked as P. Then standard was 
spotted and denoted as D. Then the TLC was placed in the TLC chamber containing 
mobile phase for elution. After sufficient elution TLC plate was removed from the TLC 
chamber and placed in an iodine chamber for detection.     
Sample preparation (stress) 
1g of Alverine citrate capsules were weighed and transferred to a petri dish. This petri 
dish was placed in a hot air over at the temperature of 50ºC. The third day, the sample 
was spotted on the TLC plate using micropipette. This was marked as P. Then standard 
was spotted and denoted as D. Then the TLC was placed in the TLC chamber containing 
mobile phase for elution. After sufficient elution TLC plate was removed from the TLC 
chamber and placed in an iodine chamber for detection.     
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PHOTOLYTIC DEGRADATION USING SUN LIGHT 
Bulk preparation stress 
1g of Alverine citrate bulk was weighed and transferred to a petri dish. This petri dish 
was placed in a sun light. The third day, the sample was spotted on the TLC plate using 
micropipette. This was marked as P. Then standard was spotted and denoted as D. Then 
the TLC was placed in the TLC chamber containing mobile phase for elution. After 
sufficient elution TLC plate was removed from the TLC chamber and placed in an iodine 
chamber for detection.    .  
Sample preparation 
1g of Alverine citrate capsules were weighed and transferred to a petri dish. This petri 
dish was placed in a sun light. The third day, the sample was spotted on the TLC plate 
using micropipette. This was marked as P. Then standard was spotted and denoted as D. 
Then the TLC was placed in the TLC chamber containing mobile phase for elution. After 
sufficient elution TLC plate was removed from the TLC chamber and placed in an iodine 
chamber for detection.     
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  HYDROLYTIC DEGRADATION STUDY USING 0.1 N HYDROCHLORIC ACID 
Hydrolytic degradation was performed as per the procedure in materials and methods. The 
assay value of standard and sample were evaluated by spectrophotometry. The respective 
UV- spectrum and the values are given in Fig.1-4, Table-8, 9. 
 
Fig. 1 Overlay Spectrum of Alverine Citrate Bulk with Standard in 0.1N HCl 
                                            30mins                                                               90mins 
 
  Fig. 2 Overlay Spectrum of Alverine Citrate Sample with Standard in 0.1N HCl 
                                            30mins                                                               90mins 
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Fig. 3 Overlay Spectrum of Alverine Citrate Bulk with Standard in 0.1N HCl 
                               
                                    1st day                                                                5th day 
 
 
 
Fig. 4 Overlay Spectrum of Alverine Citrate Sample with Standard in 0.1N HCl 
 
                                           1st day                                                                5th day 
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Table 8: Absorbance Values for Hydrolytic Degradation Using 0.1 N HCl 
 
S.No. 
 
Drug Absorbance Standard Time 
1 Bulk 0.097 0.125 30mins 
2  0.101   
3  0.093   
1 Sample 0.116   
2  0.120   
3  0.122   
1 Bulk 0.072 0.125 60mins 
2  0.080   
3  0.064   
1 Sample 0.097   
2  0.105   
3  0.089   
1 Bulk 0.061 0.125 90mins 
2  0.066   
3  0.056   
1 Sample 0.084   
2  0.078   
3  0.090   
 
Table.8.1: Results obtained from hydrolytic degradation -0.1 N HCl 
Stress 
condition 
(Acid 
Hydrolysis) 
Time Bulk Percentage 
content (%) 
Sample percentage 
content (%) 
0.1 N HCl 
30mins 77.6 92.8 
60mins 57.6 77.6 
90mins 48.8 67.2 
 
 Each value is the mean of three determinations. 
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1.2. INTERDAY STUDY: 
Table 9: Absorbance Values For Hydrolytic Degradation Using - 0.1 N HCl 
 
S.No. 
 
Drug Absorbance Standard Time 
1 Bulk 0.039 0.126 1st day 
2  0.045   
3  0.033   
1 Sample 0.093   
2  0.099   
3  0.087   
1 Bulk 0.072 0.126 3rd day 
2  0.081   
3  0.063   
1 Sample 0.087   
2  0.098   
3  0.076   
1 Bulk 0.019 0.126 5th day 
2  0.022   
3  0.016   
1 Sample 0.070   
2  0.080   
3  0.060   
 
Table.9.1: Results obtained from hydrolytic degradation - 0.1 N HCl 
Stress condition 
(Alkali hydrolysis) Time 
Bulk Percentage 
content (%) 
Sample 
percentage 
content (%) 
0.1 N Hydrochloric acid 
1stday 31.2 74.4 
3rdday 16.8 69.6 
5thday 15.1 56.0 
 
 Each value is the mean of three determinations. 
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GRAPHICAL REPRESENTATION OF INTRADAYAND INTER DAY STUDY  
 
Fig: 5 Assay Values of Bulk and Sample at Various Time Intervals 
 
 
 
 
 
 
Fig: 6 Assay Values of Bulk and Sample at Various Time Intervals 
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Alverine citrate was found to be unstable under acidic condition. Table: 8 shows the results 
of intraday degradation and the amount of standard and sample remaining in the solution 
after certain time intervals. The assay values of standard and the sample were found to be 
48.8% and 74.4% at the end of 90mins. The results of Interday degradation are given in 
Table: 9  The assay value of standard and sample was found to be 31.2% and 69.6% at the 
end of the first day acid hydrolysis. At the end of the 5th day the assay values of standard 
and sample were found to be 15.2% and 56.0%. 
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OXIDATIVE DEGRADATION USING 30% H2O2 
Oxidative degradation was performed as per the procedure in materials and methods .the 
assay value of standard and sample were evaluated by spectrophotometry. The respective 
UV- spectrum and the values are given in Fig.7-10, Table-10, 11. 
 
Fig. 7 Overlay Spectrum of Alverine Citrate Bulk with Standard in 30% H2O2 
                           30mins                                                                90mins 
 
 
Fig. 8 Overlay Spectrum of Alverine Citrate Sample with Standard in 30% H2O2 
 
                                   30mins                                                                   90mins 
 
. 
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Fig. 9 Overlay Spectrum of Alverine Citrate Bulk with Standard in 30% H2O2 
                                           1st day                                                                5th day 
 
 
Fig.10 Overlay Spectrum of Alverine Citrate Sample with Standard in 30% H2O2 
 
                            1st day                                                                5th day 
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    Table 10: Absorbance Values for Oxidative Degradation Using - 30% H2O2 
 
S.No. 
 
Drug Absorbance Standard Time 
1 Bulk 0.090 0.124 30mins 
2  0.082   
3  0.098   
1 Sample 0.097   
2  0.105   
3  0.089   
1 Bulk 0.088 0.125 60mins 
2  0.098   
3  0.078   
1 Sample 0.087   
2  0.081   
3  0.093   
1 Bulk 0.082 0.128 90mins 
2  0.088   
3  0.076   
1 Sample 0.082   
2  0.072   
3  0.092   
 
Table.10.1: Results Obtained From Oxidative Degradation - 30% H2O2 
 
Stress 
condition 
(Oxidation) 
Time Bulk Percentage 
content (%) 
Sample 
percentage 
content (%) 
30% H2O2 
30mins 71.9 77.6 
60mins 70.3 69.6 
90mins 65.5 65.6 
 
 Each value is the mean of three determinations. 
 
 
                                                                                                                                             RESULTS AND DISCUSSION 
 
DEPARTMENT OF PHARMACEUTICAL CHEMISTRY Page 51 
 
Table 11: Absorbance Values for Oxidative Degradation Using - 30% H2O2 
 
 
S.No. 
 
Drug Absorbance Standard Time 
1 Bulk 0 0.125 1st day 
2  0   
3  0   
1 Sample 0   
2  0   
3  0   
 
 
Table.11.1: Results Obtained From Oxidative Degradation - 30% H2O2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stress condition 
(Oxidation) Time 
Bulk Percentage 
content (%) 
Sample percentage 
content (%) 
30% H2O2 
1stday 0 0 
3rdday 0 0 
5thday 0 0 
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GRAPHICAL REPRESENTATION OF INTRADAY STUDY  
Fig: 11 Assay Values of Bulk and Sample at Various Time Intervals 
 
 
 
Alverine citrate was found to be unstable under oxidative stress condition. It was found that 
the stress induced standard and the test were found to degrade to 68.3% and 68.0% at the 
end of 90mins. The assay value of standard and sample was found to be 0% at the end of 
the first day of oxidative degradation. 
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THERMAL DEGRADATION 
Thermal degradation was performed as per the procedure in materials and methods. The 
assay value of standard and sample were evaluated by UV-spectrophotometry. The 
respective UV- spectrum and the values are given in Fig.12-13, Table-12. 
 
Fig. 12 Overlay Spectrum of Alverine Citrate Bulk with Standard  
 
                                           1st day                                                                5th day 
 
Fig. 13 Overlay Spectrum of Alverine Citrate Sample with Standard  
 
                                           1st day                                                                5thday   
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Table 12: Absorbance Values for Thermal at 50ºC 
 
 
S.No. 
 
Drug Absorbance Standard Time 
1 Bulk 0.085 0.126 1stday 
2  0.090   
3  0.080   
1 Sample 0.089   
2  0.098   
3  0.081   
1 Bulk 0.065 0.124 3rdday 
2  0.073   
3  0.058   
1 Sample 0.078   
2  0.071   
3  0.085   
1 Bulk 0.061 0.126 5thday 
2  0.055   
3  0.067   
1 Sample 0.061   
2  0.067   
3  0.065   
 
 
Table.12.1: Results Obtained from Thermal degradation - 50ºC 
Stress Condition 
(Thermal) Time 
Bulk Percentage 
Content (%) 
Sample Percentage 
Content (%) 
50ºC 
1stday 67.9 71.2 
3rdday 51.9 62.4 
5thday 48.7 48.8 
 
• Each value is the mean of three determinations. 
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GRAPHICAL REPRESENTATION OF INTERDAY STUDY  
 
Fig: 14 Assay Values of Bulk and Sample at Various Time Intervals 
 
 
 
Extensive degradation was observed in both standard and sample. The assay values of 
standard and sample was found to be 48.8%. It indicates that Alverine citrate was 
vulnerable to heat. 
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PHOTOLYTIC DEGRADATION 
Alverine Citrate bulk and sample were kept in sunlight. The Bulk and Sample powders 
were collected at different time intervals and the assay values were calculated by UV 
spectroscopy. The respective UV spectrum and the values are given in Fig.15-17, Table-13. 
 
Fig.16 Overlay Spectrum of Alverine Citrate Bulk with Standard  
 
                                           1st day                                                                5th day 
 
 
 
Fig.17 Overlay Spectrum of Alverine Citrate Sample with Standard  
 
                                           1st day                                                                5th day 
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    Table 13: Absorbance Values for Photolytic Degradation Using Sunlight 
 
S.No. 
 
Drug Absorbance Standard Time 
1 Bulk 0.093 0.128 1stday 
2  0.100   
3  0.060   
1 Sample 0.103   
2  0.110   
3  0.096   
1 Bulk 0.090 0.125 3rdday 
2  0.100   
3  0.080   
1 Sample 0.088   
2  0.099   
3  0.077   
1 Bulk 0.084 0.126 5thday 
2  0.091   
3  0.077   
1 Sample 0.084  
 
2  0.088   
3  0.080   
 
Table.13.1 Results Obtained After Photolytic Degradation –Sunlight 
Stress Condition 
(Photolytic) Time 
Bulk Percentage 
Content (%) 
Sample Percentage 
Content (%) 
Sunlight 
 
1stday 74.3 82.4 
3rdday 71.9 70.4 
5thday 67.1 67.2 
 
• Each value is the mean of three determinations. 
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GRAPHICAL REPRESENTATION OF INTERDAY STUDY  
Fig: 18 Assay Values of Bulk and Sample at Various Time Intervals 
 
 
 
Alverine citrate sample and standard underwent photolytic degradation in presence of 
sunlight. The assay values of standard and sample were found to be 67.1% and 67.2% 
respectively. Therefore the formulations of Alverine where have to be protected from light 
exposure.  
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2) IR STUDY OF BULK&SAMPLE-UNDER STRESS &NORMAL CONDITION: 
In interday Thermal and photolytic degradation the samples were kept in heating chamber 
and sunlight. The next day the samples were taken and ground with KBr. Then the KBr 
pellets were formed using pellet pressing technique. IR spectrum was taken for pellets. IR 
spectrum is given in Fig.19-26, Table-14. 
Thermal Degradation at 50ºC 
 Fig: 19 Overlay IR Spectrum of Standard with Bulk in 1st Day 
 
Fig: 20 Overlay IR Spectrum of Standard with Bulk 5th Day
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Fig: 21 Overlay IR Spectrum of Standard with Sample in 1st Day 
 
 
Fig: 22 Overlay IR Spectrum of Standard with Sample in 5th Day 
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Photolytic Degradation at 50ºC 
 Fig: 23 Overlay IR Spectrum of Standard with Bulk in 1st Day 
 
 
Fig: 24 Overlay IR Spectrum of Standard with Bulk 5th Day 
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Fig: 25 Overlay IR Spectrum of Standard with Sample in 1st Day 
 
 
Fig: 26 Overlay IR Spectrum of Standard with Sample in 5th Day 
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Table: 14 
BAND 
FREQUENCY 
(cm-1) 
BULK SAMPLE RESULT 
3016 C-H Stretching Aromatic 
C-H Stretching 
Aromatic 
No changes 
observed 
2962 C-H Stretching Alkane 
C-H Stretching 
Alkane 
No changes 
observed 
1458 C=C Stretching Aromatic 
C=C Stretching 
Aromatic 
No changes 
observed 
1211 C-C Stretching Alkane 
C-C Stretching 
Alkane 
No changes 
observed 
 
IR spectroscopy study was performed for interday degradation study. The study reveals 
that there are no changes in the functional group present in the Alverine citrate bulk and 
formulation by KBr pellet technique.  
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3) RP- HPLC STUDY OF BULK&SAMPLE-UNDER STRESS CONDITIONS: 
 
In RP- HPLC C-18 silica column was used for Alverine citrate assay. The mobile phase 
used in this assay was Acetonitrile and Sodium Lauryl Sulphate in the ratio of (1:1).     
1ml/minute flow rate was maintained. The retention time of Alverine citrate was found to 
be 7.9. Chromatogram of Alverine citrate is given Fig.27 
 
Fig: 27 CHROMATOGRAM OF ALVERINE CITRATE  
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INTRA DAY STUDY 
Fig: 28 Chromatogram of Alverine citrate Bulk in 0.1N HCl (90mins) 
 
 
 
Fig: 29 Chromatogram of Alverine citrate Sample in 0.1N HCl (90mins) 
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Fig: 30 Chromatogram of Alverine citrate Bulk in 30% H2O2 (90mins) 
 
 
 
Fig: 31 Chromatogram of Alverine citrate Sample in 30% H2O2 (90mins) 
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3.1) Intraday Study Results For Degradation (Table: 15) 
 
Stress condition 
 
Time Bulk Peak Area Sample Peak Area 
 
0.1N HCl(Acid) 90mins 
 
169 
 
219 
 
30% H2O2(Oxidation) 90mins 
 
225 
 
234 
 
 
 
 
 
 
 
RP–HPLC study of Intraday degradation shows that moderate amount of degradation has 
occurred. Compared to oxidative degradation acid degradation was more prominent in the 
sample. 
 
 
 
 
 
 
 
 
 
Stress condition 
 
Time Bulk Percentage Content (%) 
Sample percentage 
Content (%) 
 
0.1N HCl(Acid) 90mins 
 
50.1 
 
65.0 
 
30%  H2O2 (Oxidation) 90mins 
 
66.6 
 
69.4 
                                                                                                                                             RESULTS AND DISCUSSION 
 
 
INTERDAY STUDY 
Fig: 32 Chromatogram of Alverine citrate Bulk in 0.1N HCl (3rd day) 
 
 
Fig: 33 Chromatogram of Alverine citrate Sample in 0.1N HCl (3rd day) 
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Fig: 34 Chromatogram of Alverine citrate Bulk in 30% H2O2 (3rd day) 
 
 
 
 
Fig: 35 Chromatogram of Alverine citrate Sample in 30% H2O2 (3rd day) 
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Fig: 36 Chromatogram of Alverine citrate Bulk (Thermal 3rd day) 
 
 
 
Fig: 37 Chromatogram of Alverine citrate Sample (Thermal 3rd day) 
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Fig: 38 Chromatogram of Alverine citrate Bulk (Sun light 3rd day) 
 
 
 
Fig: 39 Chromatogram of Alverine citrate Sample (Sun light 3rd day) 
\ 
 
 
 
 
 
 
                                                                                                                                             RESULTS AND DISCUSSION 
 
DEPARTMENT OF PHARMACEUTICAL CHEMISTRY Page 72 
 
 
Interday Study Results for Degradation (Table: 16) 
Stress condition 
 
Time Bulk Peak Area Sample Peak Area 
 
0.1N HCl(Acid) 3
rd
 Day  65 
 
240 
 
30% H2O2(Oxidation) 3
rd
 Day - - 
 
Thermal (50ºC) 3
rd
 Day  188 
 
199 
 
Sunlight (Photolysis) 3
rd
 Day  250 
 
238 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interday degradation study   in HPLC shows that the more amount of degradation was seen 
in bulk compared to standard. Complete degradation was observed in Interday oxidative 
degradation. Extensive degradation was observed in acid hydrolysis. Thermal and 
Photolytic degradation showed moderate amount of degradation. In Thermal bulk has 
undergone more amount of degradation. In Photolytic degradation sample has undergone 
more amount of degradation. 
In 
 
 
 
 
 
Stress condition 
 
Time Bulk Percentage Content (%) 
Bulk Percentage 
Content (%) 
 
0.1N HCl(Acid) 3
rd
 Day  16.8 
 
71.2 
 
30% H2O2(Oxidation) 3
rd
 Day - - 
 
Thermal (50ºC) 3
rd
 Day 55.7 59.0 
 
Sunlight (Photolysis) 3
rd
 Day  74.1 
 
70.6 
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 4. THIN LAYER CHROMATOGRAPHY  
TLC is used for identification of degraded products. The mobile phase used for degradation 
of Alverine citrate was found to be Chloroform and methanol in the ratio of 9:1. Various 
mobile phases were tried for Alverine citrate .The results of intraday and interday are given 
Table17 and 18 respectively. 
 
4.1. Intraday study results (Table: 17) 
 
4.2. Interday Degradation Study results. (Table: 18) 
 
 
 
STRESS 
CONDITION 
 
SAMPLE 
TYPE 
 
NO OF 
SPOTS 
 
SECONDARY 
SPOTS 
 
Rf VALUE 
 
Acid Hydrolysis 
0.1N HCl 
 
Bulk 
 
1 
 
0 
 
0.52 
 
Sample 
 
1 
 
0 
 
0.53 
 
Oxidative Degradation 
30% H2O2 
 
Bulk 
 
1 
 
0 
 
0.55 
 
Sample 
 
1 
 
0 
 
0.53 
 
STRESS CONDITION 
 
SAMPLE 
TYPE 
 
NO OF 
SPOTS 
 
SECONDARY 
SPOTS 
 
Rf VALUE 
 
Acid Hydrolysis 
0.1N HCl 
 
Bulk 
 
1 
 
0 
 
0.41 
 
Sample 
 
1 
 
0 
 
0.46 
 
Oxidative Degradation 
30% H2O2 
 
Bulk 
 
0 
 
0 
 
0 
 
Sample 
 
0 
 
0 
 
0 
 
Thermal Degradation 
 
Bulk 
 
1 
 
0 
 
0.45 
 
Sample 
 
1 
 
0 
 
0.42 
 
Photolytic 
Degradation 
 
Bulk 
 
1 
 
0 
 
0.48 
 
Sample 
 
1 
 
0 
 
0.49 
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Intraday TLC study shows that there is no secondary spot and shows the amount of 
degradation. Rf values of bulk and sample were found to be 0.52 and 0.53 respectively for 
intraday acid degradation. In interday oxidative degradation no spot was observed in 
standard and sample. This indicates that complete degradation of Alverine citrate standard 
and sample. 
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SUMMARY AND CONCLUSION 
 
The present work entitled as “FORCED DEGRADATION STUDIES OF ALVERINE 
CITRATE IN BULK AND FORMULATION BY UV, IR 
SPECTROPHOTOMETRY, TLC, AND RP-HPLC METHOD” is a study 
about the stability of Alverine citrate in various conditions. 
The study comprises of  
 Alkali hydrolysis, Oxidative degradation, and Thermal and Photolytic degradation 
were performed. 
 Degraded samples were quantified by UV spectroscopy and HPLC. 
 |The results of bulk and sample compared with standard. 
 Degraded samples were identified by TLC. 
 Functional group changes in degraded samples were identified by IR. 
 
Every procedure was repeated three times. Various stress conditions were tried to study 
the stability of Alverine citrate. The stress conditions used are Alkali, Acid hydrolysis, 
Oxidative degradation, Thermal and Photolytic degradation. 
The results of the studies are 
In intraday hydrolytic degradation, bulk underwent more degradation compared to 
sample from 30mins to 90mins study. 
In interday acid degradation, the assay values of bulk and sample were found to be 15.1% 
and 56.0% respectively, at the end of 5th day degradation. 
Complete degradation was observed in interday oxidative degradation. It shows that 
Alverine citrate is vulnerable to oxidative condition.  
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Moderate amount of degradation was observed in both Photolytic and Thermal 
degradation. 
IR spectrum shows that no functional group changes were observed in both Photolytic 
and Thermal degradation. 
HPLC chromatogram shows that formation of impurities in intraday oxidative 
degradation. 
Interday oxidative degradation chromatogram shows complete degradation and more 
amounts of degradation products. 
No impurity peak was observed in both Photolytic and Thermal degradation 
chromatogram. 
No secondary spots were observed in TLC but difference in Rf value was observed. 
All the observations show Alverine citrate is vulnerable to Alkali hydrolysis, Oxidation, 
Thermal and Photolytic degradation. 
The future scope of study includes the determination of degradation pathways of drug 
substance and drug product. Identification of degraded products in formulation that are 
related to drug substance versus those that are related to non-drug substance (Additives, 
Excipients). Structural elucidation of degraded fragment and determination of intrinsic 
stability of drug substances. 
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